# Ypsomed opens production site in Changzhou, China

Ypsomed opened its first dedicated production site in Changzhou, China, with an investment of nearly CHF 150 million. The facility will manufacture up to 100 million injection systems annually for the Chinese market.

- Type: New facility
- Announced: 2025-06-27
- Where: Changzhou, Jiangsu, China
- Value: $168.0M (150.0M CHF)
- Jobs: 100
- Starts operating: 26 Jun 2025
- Status: completed
- Capacity: 100 million injection systems per year
- Products: injection systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md)

## Sources

- [ypsomed.com](https://www.ypsomed.com/en/news-insights/news/press-releases/news-reader-detail-page/ypsomed-opens-production-site-in-china), 2025-06-27: "Opening our own factory in China is not just a strategic investment – it reflects our long-term commitment and confidence in the Chinese market."
- [biospectrumasia.com](https://www.biospectrumasia.com/news/27/26297/medtech-manufacturer-ypsomed-opens-first-production-facility-in-china.html), 2025-07-03: "Going forward, up to 100 million injection systems will be manufactured here each year for the Chinese market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.